Dr. Johri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6600 West Broad Street
Ste 300
Richmond, VA 23230
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
- Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1997 - 2000
- Rajendra Medical CollegeClass of 1991
Certifications & Licensure
- VA State Medical License 2002 - 2026
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 61 citationsInhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE studySteven D. Nathan, Aaron B. Waxman, Sudarshan Rajagopal, Amy Case, Shilpa Johri
The Lancet. Respiratory Medicine. 2021-11-01 - 6 citationsSurvival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.Steven D Nathan, Shilpa Johri, Joanna M Joly, Christopher S King, Amresh Raina
Thorax. 2024-03-15 - 11 citationsBREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hyperten...Leslie A Spikes, Abubakr A Bajwa, Charles D Burger, Sapna V Desai, Michael S Eggert
Pulmonary Circulation. 2022-04-01
Press Mentions
- C NotesApril 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: